Cargando…
Growth Differentiation Factor-15 in Asian IHD Patients: Should We Use to Guide Therapeutic Decision?
[Figure: see text]
Autor principal: | Jang, Jae-Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308089/ https://www.ncbi.nlm.nih.gov/pubmed/37396426 http://dx.doi.org/10.1016/j.jacasi.2023.04.004 |
Ejemplares similares
-
Sex Differences in the Pathophysiology, Treatment, and Outcomes in IHD
por: Sanghavi, Monika, et al.
Publicado: (2015) -
CVVH versus IHD in patients with multiple organ failure
por: Gašparović, V, et al.
Publicado: (2003) -
The recent advances, drawbacks, and the future directions of CMRI in the diagnosis of IHD
por: Fagiry, Moram A., et al.
Publicado: (2021) -
Epitranscriptomics of Ischemic Heart Disease—The IHD-EPITRAN Study Design and Objectives
por: Sikorski, Vilbert, et al.
Publicado: (2021) -
The Plasma B-Type Natriuretic Peptide Levels Are Low in Males with Stable Ischemic Heart Disease (IHD) Compared to Those Observed in Patients with Non-IHD: A Retrospective Study
por: Minai, Kosuke, et al.
Publicado: (2014)